A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
MILESTONE SCIENTIFIC INC.
MLSS
$31M
Mkt Cap
$0.39
-2.45%
MILESTONE SCIENTIFIC INC. (MLSS) has a 5-year average return on invested capital (ROIC) of -80.0%. This is below average and may indicate limited pricing power.
MILESTONE SCIENTIFIC INC. (MLSS) has a market capitalization of $31M. It is classified as a small-cap stock.
MILESTONE SCIENTIFIC INC. (MLSS) does not currently pay a regular dividend.
MILESTONE SCIENTIFIC INC. (MLSS) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
MILESTONE SCIENTIFIC INC. (MLSS) reported annual revenue of $9 million in its most recent fiscal year, based on SEC EDGAR filings.
MILESTONE SCIENTIFIC INC. (MLSS) has a net profit margin of -54.6%. The company is currently unprofitable.
MILESTONE SCIENTIFIC INC. (MLSS) generated $-3 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
MILESTONE SCIENTIFIC INC. operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 9.0M | 8.6M | 9.8M | 8.8M | 10M | 5.4M |
| Net Income | -5.7M | -4.7M | -6.9M | -8.7M | -6.8M | -7.3M |
| EPS | $-0.07 | $-0.06 | $-0.10 | $-0.12 | $-0.10 | $-0.12 |
| Free Cash Flow | 0 | -2.9M | -5.3M | -6.0M | -4.0M | -7.0M |
| ROIC | -180.0% | -182.6% | -228.8% | -65.4% | -41.8% | -30.1% |
| Gross Margin | 71.4% | 74.6% | 69.1% | 55.7% | 61.3% | 66.6% |
| Debt/Equity | 0.28 | 0.06 | 0.05 | 0.05 | 0.04 | 0.06 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -5.7M | -6.8M | -7.1M | -8.8M | -7.4M | -7.5M |
| Operating Margin | -63.5% | -78.3% | -72.3% | -100.2% | -71.6% | -137.1% |
| ROE | -203.4% | -68.1% | -76.0% | -65.5% | -41.9% | -82.0% |
| Shares Outstanding | 80M | 79M | 69M | 73M | 68M | 61M |
| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 10M | 10M | 9.5M | 10M | 11M | 9.6M | 8.4M | 5.4M | 10M | 8.8M | 9.8M | 8.6M | 9.0M |
| Gross Margin | 68.0% | 64.9% | 67.9% | 60.2% | 61.8% | 46.1% | 68.3% | 66.6% | 61.3% | 55.7% | 69.1% | 74.6% | 71.4% |
| R&D | 191K | 88K | 101K | 1.3M | 273K | 246K | 190K | 308K | 878K | 1.2M | 701K | 859K | 449K |
| SG&A | 5.5M | 7.4M | 9.4M | 12M | 12M | 11M | 9.5M | 11M | 13M | 13M | 13M | 12M | 12M |
| EBIT | 1.1M | -790K | -3.1M | -6.5M | -5.2M | -8.0M | -4.0M | -7.5M | -7.4M | -8.8M | -7.1M | -6.8M | -5.7M |
| Op. Margin | 10.9% | -7.6% | -32.2% | -62.1% | -46.4% | -83.1% | -47.8% | -137.1% | -71.6% | -100.2% | -72.3% | -78.3% | -63.5% |
| Net Income | 1.5M | -1.7M | -5.5M | -5.9M | -5.2M | -7.4M | -7.5M | -7.3M | -6.8M | -8.7M | -6.9M | -4.7M | -5.7M |
| Net Margin | 14.6% | -16.5% | -57.6% | -56.7% | -46.0% | -77.2% | -89.8% | -134.9% | -66.2% | -98.9% | -70.5% | -54.6% | -63.8% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 544K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | 35.0% | -11.6% | -53.0% | -70.0% | -71.6% | N/M | -48.2% | -30.1% | -41.8% | -65.4% | N/M | -182.6% | -180.0% |
| ROE | 39.3% | -16.9% | -43.8% | -63.2% | -65.9% | -169.2% | -465.1% | -82.0% | -41.9% | -65.5% | -76.0% | -68.1% | -203.4% |
| ROA | 21.4% | -13.3% | -36.1% | -44.1% | -34.8% | -67.5% | -116.1% | -56.2% | -34.6% | -52.0% | -55.3% | -44.5% | -73.3% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 1.3M | 377K | -2.9M | -5.4M | -1.2M | -1.6M | -1.8M | -7.0M | -4.0M | -6.0M | -5.3M | -2.9M | -2.9M |
| Free Cash Flow | 1.3M | 295K | -3.0M | -5.4M | -1.2M | -1.6M | -1.8M | -7.0M | -4.0M | -6.0M | -5.3M | -2.9M | 0 |
| Owner Earnings | 744K | -468K | -3.6M | -7.9M | -2.5M | -2.9M | -2.1M | -7.6M | -4.9M | -7.6M | -6.9M | -4.3M | -3.9M |
| CapEx | 6K | 82K | 68K | 15K | 6K | 7K | 10K | 21K | 15K | 9K | 0 | 10K | 0 |
| Maint. CapEx | 477K | 416K | 566K | 659K | 573K | 881K | 101K | 96K | 74K | 64K | 62K | 37K | 78K |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | N/A | 0 | 0 |
| D&A | 477K | 416K | 566K | 659K | 573K | 881K | 101K | 96K | 74K | 64K | 62K | 37K | 78K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 37K | 429K | 50K | 1.9M | 651K | 409K | 184K | 550K | 791K | 1.5M | 1.5M | 1.3M | 953K |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | -8.4M | N/A | N/A | N/A | N/A | -1.8M | -26M | -29M | -17M | -5.6M | -2.9M | -313K |
| Cash & Equiv. | 1.1M | 10M | 4.2M | 3.6M | 2.6M | 743K | 1.5M | 14M | 15M | 8.7M | 3.0M | 3.3M | 1.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 29K | 20K | 11K | 0 | 55K | 27K |
| Debt/Equity | 0.46 | 0.14 | 0.35 | 0.66 | 1.12 | 3.16 | 0.01 | 0.06 | 0.04 | 0.05 | 0.05 | 0.06 | 0.28 |
| Interest Coverage | 15.3 | -296.2 | N/A | N/A | N/A | -1074.2 | -2591.7 | -412.2 | -451.0 | -161.7 | -56.6 | -112.1 | -112.1 |
| Equity | 5.5M | 15M | 10M | 8.5M | 7.2M | 1.5M | 1.7M | 16M | 16M | 10M | 8.0M | 5.8M | 2.8M |
| Total Assets | 8.1M | 17M | 13M | 14M | 16M | 6.4M | 6.6M | 20M | 20M | 14M | 11M | 9.8M | 7.8M |
| Total Liabilities | 2.5M | 2.5M | 3.6M | 5.6M | 8.1M | 4.9M | 4.9M | 3.5M | 3.6M | 3.7M | 3.4M | 4.0M | 5.0M |
| Intangibles | 592K | 530K | 716K | 660K | 2.8M | 435K | 382K | 329K | 278K | 228K | 179K | 148K | 79K |
| Retained Earnings | -60M | -62M | -67M | -73M | -79M | -86M | -94M | -101M | -108M | -116M | -123M | -128M | -134M |
| Working Capital | 2.3M | 13M | 8.2M | 7.7M | 5.3M | 984K | 1.1M | 16M | 16M | 9.7M | 7.7M | 5.5M | 3.3M |
| Current Assets | 4.9M | 16M | 12M | 13M | 12M | 5.9M | 6.1M | 19M | 19M | 13M | 11M | 9.3M | 7.5M |
| Current Liabilities | 2.5M | 2.4M | 3.6M | 5.6M | 6.7M | 4.9M | 4.9M | 2.9M | 3.1M | 3.3M | 3.1M | 3.7M | 4.1M |
| Per Share Data | |||||||||||||
| EPS | 0.08 | -0.08 | -0.26 | -0.22 | -0.16 | -0.21 | -0.16 | -0.12 | -0.10 | -0.12 | -0.10 | -0.06 | -0.07 |
| Owner EPS | 0.04 | -0.02 | -0.17 | -0.29 | -0.08 | -0.08 | -0.04 | -0.12 | -0.07 | -0.10 | -0.10 | -0.05 | -0.05 |
| Book Value | 0.30 | 0.69 | 0.49 | 0.31 | 0.22 | 0.04 | 0.04 | 0.26 | 0.24 | 0.14 | 0.12 | 0.07 | 0.03 |
| Cash Flow/Share | 0.07 | 0.02 | -0.14 | -0.20 | -0.04 | -0.05 | -0.04 | -0.11 | -0.06 | -0.08 | -0.08 | -0.04 | -0.07 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 18.3M | 21.3M | 21.0M | 27.0M | 32.4M | 35.4M | 47.0M | 61.1M | 68.2M | 72.6M | 69.3M | 78.6M | 80.5M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -5.4 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | 5.0 | 7.1 | 38.3 | 7.5 | 9.0 | 3.4 | 6.5 | 11.8 | 11.2 |
| Price/Sales | N/A | N/A | N/A | N/A | 3.8 | 2.8 | 3.5 | 20.0 | 16.7 | 9.1 | 6.9 | 7.0 | 3.5 |
| FCF Yield | N/A | N/A | N/A | N/A | -3.4% | -14.9% | -2.8% | -5.8% | -2.8% | -17.1% | -10.3% | -4.2% | N/A |
| Market Cap | 0 | 0 | 0 | 0 | 36M | 11M | 65M | 122M | 147M | 35M | 52M | 69M | 31M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 1.32 | 0.77 | 0.63 | 1.78 | 2.46 | 1.04 | 0.87 | 0.77 | 0.39 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 | 0.31 | 1.38 | 1.99 | 2.10 | 0.46 | 0.66 | 0.88 | 0.39 |
MILESTONE SCIENTIFIC INC. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 65.4%.
MILESTONE SCIENTIFIC INC. (MLSS) has a debt-to-equity ratio of 0.06. This indicates a conservatively financed balance sheet.
MILESTONE SCIENTIFIC INC. (MLSS) reported earnings per share (EPS) of $-0.06 in its most recent fiscal year.
MILESTONE SCIENTIFIC INC. (MLSS) has a return on equity (ROE) of -68.1%. A negative ROE may indicate losses or negative equity.
MILESTONE SCIENTIFIC INC. (MLSS) has a 5-year average gross margin of 65.4%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 15 years of financial data for MILESTONE SCIENTIFIC INC. (MLSS), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
MILESTONE SCIENTIFIC INC. (MLSS) has a book value per share of $0.07, based on its most recent annual SEC filing.